Ignite Creation Date:
2025-12-24 @ 9:42 PM
Ignite Modification Date:
2026-05-30 @ 3:15 PM
Study NCT ID:
NCT00791232
Status:
COMPLETED
Last Update Posted:
2011-06-08
First Post:
2008-11-13
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study of Extended Release Extended-release (ER) OROS Paliperidone Tolerability, as Compared to Immediate-release (IR)Risperidone, in Patients With Schizophrenia
Sponsor:
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
CR004273
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None